Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole interaction study with PHA-022121 in healthy volunteers
NL-OMON49496Completed
- Sponsor
- Pharvaris
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of deucrictibant and itraconazole in hereditary angioedema (HAE), sponsored by Pharvaris. Primary endpoints: Maximum observed plasma concentration of PHA-022121, Area under the plasma concentration-time curve to last quantifiable concentration of PHA-022121 and 1 more. Started Feb 2020; status: completed.
02
Drugs
deucrictibantitraconazole
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NL-OMON49496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49496.